Patent application number | Description | Published |
20120140042 | WARNING A USER ABOUT ADVERSE BEHAVIORS OF OTHERS WITHIN AN ENVIRONMENT BASED ON A 3D CAPTURED IMAGE STREAM - A computer-implemented method, system, and program includes a behavior processing system for capturing a three-dimensional movement of a monitored user within a particular environment monitored by a supervising user, wherein the three-dimensional movement is determined by using at least one image capture device aimed at the monitored user. The behavior processing system identifies a three-dimensional object properties stream using the captured movement. The behavior processing system identifies a particular defined adverse behavior of the monitored user represented by the three-dimensional object properties stream by comparing the identified three-dimensional object properties stream with multiple adverse behavior definitions. In response to identifying the particular defined adverse behavior from among the multiple adverse behavior definitions, the behavior processing system triggers a warning system to notify the supervising user about the particular defined adverse behavior of the monitored user through an output interface only detectable by the supervising user. | 06-07-2012 |
20120271785 | ADJUSTING A CONSUMER EXPERIENCE BASED ON A 3D CAPTURED IMAGE STREAM OF A CONSUMER RESPONSE - A survey controller receives response records from response processing systems, wherein the response records comprise a selection of response records each identifying a separate response of at least one consumer to a particular stimulus within a consumer environment detected from a three-dimensional movement of the at least one consumer captured within the consumer environment. The survey controller stores response records in a response database. The survey controller calculates, from the selection of response records stored in the response database, statistics associated with the particular stimulus within the consumer environment. The survey controller stores, by the survey controller, the calculated statistics. | 10-25-2012 |
20160092725 | WARNING A USER ABOUT ADVERSE BEHAVIORS OF OTHERS WITHIN AN ENVIRONMENT BASED ON A 3D CAPTURED IMAGE STREAM - A tactile feedback output device receives one or more warning signals for controlling one or more types of tactile output by the one or more tactile feedback output devices, the one or more warning signals representing that a predicted behavior of a monitored user represents a particular behavior that is potentially adverse and a percentage probability that the predicted behavior is adverse, the monitored user detected within a particular environment monitored by a supervising user, the one or more tactile feedback output devices worn by the supervising user. | 03-31-2016 |
Patent application number | Description | Published |
20090246183 | eNOS mutations useful for gene therapy and therapeutic screening - The present invention relates to new NOS variants or mutants which contain structural alterations in the site of Akt dependent phosphorylation. The altered NOS proteins or peptides, especially the human eNOS proteins or peptides, Akt proteins or polypeptides and their encoding nucleic acid molecules are useful as gene therapy agents for the treatment of diseases including post angioplasty restenosis, hypertension, atherosclerosis, heart failure, diabetes and diseases with defective angiogenesis. NOS proteins and peptides are also useful in methods of screening for agents which modulate NOS activity. | 10-01-2009 |
20090305971 | Nogo-B Receptor - Nogo-B receptors bind to Nogo-B and mediate its biological function. We have discovered that Nogo-B receptor is a component of endothelial cells, and is highly expressed in intact blood vessels. The present invention provides compositions comprising the Nogo-B receptor and fragments and fusion proteins thereof. The present invention also relates to nucleic acids encoding the Nogo-B receptor and fragments and fusion proteins thereof, as well as vectors and cells comprising such nucleic acids. The present invention also relates to antibodies specific for the Nogo-B receptor and fragments and fusion proteins thereof. The present invention also provides methods for preventing, detecting and treating Nogo-B receptor-related diseases, disorders and conditions. | 12-10-2009 |
20110173711 | eNos Mutations Useful for Gene Therapy and Therapeutic Screening - The present invention relates to new NOS variants or mutants which contain structural alterations in the site of Akt dependent phosphorylation. The altered NOS proteins or peptides, especially the human eNOS proteins or peptides, Akt proteins or polypeptides and their encoding nucleic acid molecules are useful as gene therapy agents for the treatment of diseases including post angioplasty restenosis, hypertension, atherosclerosis, heart failure, diabetes and diseases with defective angiogenesis. NOS proteins and peptides are also useful in methods of screening for agents which modulate NOS activity. | 07-14-2011 |
20120149651 | Caveolin peptides and their use as therapeutics - The present invention relates generally to compositions and methods useful for treating various conditions and afflictions, such as inflammation and cancer. More specifically, the present invention relates to compositions and methods of treatment which utilize peptides comprising at least one caveolin scaffolding domain. Even more specifically, the present invention relates to compositions of fusion peptides comprising the antennapedia homeodomain fused to a caveolin scaffolding domain and to methods of using these peptides to treat various conditions and afflictions. | 06-14-2012 |
20150141340 | METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS - The present invention provides methods for inhibiting ocular angiogenesis, vascular leakage, and/or edema. The methods comprise administering to a subject an agent comprising a caveolin scaffolding domain. The present invention further encompasses methods of treating and/or preventing ophthalmic conditions that are associated with ocular angiogenesis, vascular leakage, or edema. | 05-21-2015 |